CEMVAYA Trademark

Trademark Overview


On Tuesday, September 2, 2025, a trademark application was filed for CEMVAYA with the United States Patent and Trademark Office. The USPTO has given the CEMVAYA trademark a serial number of 99369025. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Thursday, October 30, 2025. This trademark is owned by ModernaTx, Inc.. The CEMVAYA trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
cemvaya

General Information


Serial Number99369025
Word MarkCEMVAYA
Filing DateTuesday, September 2, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateThursday, October 30, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 18, 2025

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 2, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, September 2, 2025NEW APPLICATION ENTERED
Tuesday, September 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 2, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, October 22, 2025ASSIGNED TO EXAMINER
Wednesday, October 22, 2025APPROVED FOR PUB - PRINCIPAL REGISTER

Related Keywords


cemvaya human vaccines